Combined Treatment of Hyperbaric Oxygen and Anti-vascular Endothelial Growth Factor Therapy in Cilioretinal Artery Occlusion Associated With Central Retinal Vein Occlusion.

What Researchers Did

Researchers reported a case of a male in his early 40s with cilioretinal artery occlusion secondary to central retinal vein occlusion, who was treated with hyperbaric oxygen therapy and an intravitreal anti-vascular endothelial growth factor injection.

What They Found

The patient achieved full and sustained anatomical and functional recovery, with visual acuity improving from 8/10 to 10/10. This suggests a potential synergistic benefit of combining anti-vascular endothelial growth factor therapy with hyperbaric oxygen therapy for mixed retinal vascular occlusion.

What This Means for Canadian Patients

For Canadian patients experiencing mixed retinal vascular occlusion, this case suggests that a combined approach of hyperbaric oxygen therapy and anti-vascular endothelial growth factor injections could be a beneficial treatment option. This strategy may help improve visual outcomes by addressing both oxygen deprivation and high venous pressure in the eye.

Canadian Relevance

This study has no direct Canadian connection as it is a single case report from an unspecified location outside of Canada.

Study Limitations

A significant limitation of this study is that it is a single case report, meaning its findings cannot be generalized to a broader patient population.